Nicola A. Hanania, MD, MS
Nicola A. Hanania, MD, MS
Verified email at - Homepage
Cited by
Cited by
Lebrikizumab treatment in adults with asthma
J Corren, RF Lemanske Jr, NA Hanania, PE Korenblat, MV Parsey, ...
New England Journal of Medicine 365 (12), 1088-1098, 2011
Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of …
A Qaseem, TJ Wilt, SE Weinberger, NA Hanania, G Criner, ...
Annals of internal medicine 155 (3), 179-191, 2011
Anxiety and depression in COPD: current understanding, unanswered questions, and research needs
J Maurer, V Rebbapragada, S Borson, R Goldstein, ME Kunik, ...
Chest 134 (4), 43S-56S, 2008
Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study
NA Hanania, S Wenzel, K Rosén, HJ Hsieh, S Mosesova, DF Choy, P Lal, ...
American journal of respiratory and critical care medicine 187 (8), 804-811, 2013
Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial
NA Hanania, O Alpan, DL Hamilos, JJ Condemi, I Reyes-Rivera, J Zhu, ...
Annals of internal medicine 154 (9), 573-582, 2011
The UK prospective diabetes study: a review
RC Turner
Diabetes care 21 (Supplement 3), C35-C38, 1998
The efficacy and safety of fluticasone propionate (250 μg)/salmeterol (50 μg) combined in the Diskus inhaler for the treatment of COPD
NA Hanania, P Darken, D Horstman, C Reisner, B Lee, S Davis, T Shah
Chest 124 (3), 834-843, 2003
Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes
MLK Han, EA Kazerooni, DA Lynch, LX Liu, S Murray, JL Curtis, GJ Criner, ...
Radiology 261 (1), 274-282, 2011
Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies
NA Hanania, M Noonan, J Corren, P Korenblat, Y Zheng, SK Fischer, ...
Thorax 70 (8), 748-756, 2015
Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials
NA Hanania, P Korenblat, KR Chapman, ED Bateman, P Kopecky, ...
The Lancet Respiratory Medicine 4 (10), 781-796, 2016
Medical personnel's knowledge of and ability to use inhaling devices: metered-dose inhalers, spacing chambers, and breath-actuated dry powder inhalers
NA Hanania, R Wittman, S Kesten, KR Chapman
Chest 105 (1), 111-116, 1994
Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort
NA Hanania, H Müllerova, NW Locantore, J Vestbo, ML Watkins, ...
American journal of respiratory and critical care medicine 183 (5), 604-611, 2011
Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised …
MT Dransfield, J Bourbeau, PW Jones, NA Hanania, DA Mahler, J Vestbo, ...
The Lancet Respiratory Medicine 1 (3), 210-223, 2013
Bronchial thermoplasty: long-term safety and effectiveness in patients with severe persistent asthma
ME Wechsler, M Laviolette, AS Rubin, J Fiterman, JRL e Silva, PL Shah, ...
Journal of allergy and clinical immunology 132 (6), 1295-1302. e3, 2013
Adverse effects of inhaled corticosteroids
NA Hanania, KR Chapman, S Kesten
The American journal of medicine 98 (2), 196-208, 1995
Prevention of acute exacerbations of COPD: American college of chest physicians and Canadian thoracic society guideline
GJ Criner, J Bourbeau, RL Diekemper, DR Ouellette, D Goodridge, ...
Chest 147 (4), 894-942, 2015
Asthma Control Questionnaire in children: validation, measurement properties, interpretation
EF Juniper, K Gruffydd-Jones, S Ward, K Svensson
European Respiratory Journal 36 (6), 1410-1416, 2010
Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort
H Müllerova, DJ Maselli, N Locantore, J Vestbo, JR Hurst, JA Wedzicha, ...
Chest 147 (4), 999-1007, 2015
Asthma in the elderly: current understanding and future research needs—a report of a National Institute on Aging (NIA) workshop
NA Hanania, MJ King, SS Braman, C Saltoun, RA Wise, P Enright, ...
Journal of Allergy and Clinical Immunology 128 (3), S4-S24, 2011
Revisiting T ype 2‐high and T ype 2‐low airway inflammation in asthma: current knowledge and therapeutic implications
D Robinson, M Humbert, R Buhl, AA Cruz, H Inoue, S Korom, NA Hanania, ...
Clinical & Experimental Allergy 47 (2), 161-175, 2017
The system can't perform the operation now. Try again later.
Articles 1–20